A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia

BACKGROUND: This double-blind (DB), randomized, parallel-group study was designed to evaluate efficacy and safety of paliperidone palmitate 6-month (PP6M) formulation relative to paliperidone palmitate 3-month (PP3M) formulation in patients with schizophrenia. METHODS: Following screening, patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Najarian, Dean, Sanga, Panna, Wang, Steven, Lim, Pilar, Singh, Arun, Robertson, Mary Jane, Cohen, Kristin, Schotte, Alain, Milz, Ruth, Venkatasubramanian, Raja, T’Jollyn, Huybrecht, Walling, David P, Galderisi, Silvana, Gopal, Srihari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929757/
https://www.ncbi.nlm.nih.gov/pubmed/34791283
http://dx.doi.org/10.1093/ijnp/pyab071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929757/
https://www.ncbi.nlm.nih.gov/pubmed/34791283
http://dx.doi.org/10.1093/ijnp/pyab071

Ejemplares similares